ALFREDO
RODRÍGUEZ ANTOLÍN
Profesor asociado de Ciencias de la Salud
Universidad de Navarra
Pamplona, EspañaUniversidad de Navarra-ko ikertzaileekin lankidetzan egindako argitalpenak (6)
2022
-
Corrigendum to <‘Mitomycin C allergy after passive and device-assisted hyperthermia for non-muscle invasive bladder cancer treatment: A retrospective cohort from a high-volume center’> <[Volume 40, Issue 7, July 2022, Pages 345.e19-345.e23]> (Urologic Oncology: Seminars and Original Investigations (2022) 40(7) (345.e19–345.e23), (S1078143922000679), (10.1016/j.urolonc.2022.02.018))
Urologic Oncology: Seminars and Original Investigations
-
Mitomycin C allergy after passive and device-assisted hyperthermia for non-muscle invasive bladder cancer treatment: A retrospective cohort from a high-volume center
Urologic Oncology: Seminars and Original Investigations, Vol. 40, Núm. 7, pp. 345.e19-345.e23
-
Recirculating hyperthermic intravesical chemotherapy with mitomycin C (HIVEC) versus BCG in high-risk non-muscle-invasive bladder cancer: results of the HIVEC-HR randomized clinical trial
World Journal of Urology, Vol. 40, Núm. 4, pp. 999-1004
2021
-
Quality of life and adverse events in patients with nonmuscle invasive bladder cancer receiving adjuvant treatment with BCG, MMC, or chemohyperthermia
Urologic Oncology: Seminars and Original Investigations, Vol. 39, Núm. 1, pp. 76.e9-76.e14
2020
-
Manejo de la hiperplasia benigna de próstata durante la pandemia COVID-19
Archivos espanoles de urologia, Vol. 73, Núm. 5, pp. 405-412
2019
-
Factors related to early castration resistance in metastatic prostate cancer. Results from the National Prostate Cancer Registry in Spain
Actas Urologicas Espanolas, Vol. 43, Núm. 10, pp. 562-567